Doxorubicin, mesenchymal stem cell toxicity and antitumour activity: implications for clinical use
© 2018 Royal Pharmaceutical Society Objectives: The use of doxorubicin, an antineoplastic medication used for the treatment of cancers via mechanisms that prevent replication of cells or lead to their death, can result in damage to healthy cells as well as malignant. Among the affected cells are me...
| Main Authors: | Baxter-Holland, M., Dass, Crispin |
|---|---|
| Format: | Journal Article |
| Published: |
John Wiley & Sons Ltd.
2018
|
| Online Access: | http://hdl.handle.net/20.500.11937/67187 |
Similar Items
Doxorubicin-induced death in tumour cells and cardiomyocytes: is autophagy the key to improving future clinical outcomes?
by: Tacar, O., et al.
Published: (2013)
by: Tacar, O., et al.
Published: (2013)
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
by: Tacar, O., et al.
Published: (2013)
by: Tacar, O., et al.
Published: (2013)
Novel pH-responsive dextrin nanogels for doxorubicin delivery to cancer cells with reduced cytotoxicity to cardiomyocytes and stem cells
by: Manchun, S., et al.
Published: (2014)
by: Manchun, S., et al.
Published: (2014)
Doxorubicin: The dogma and the bone
by: Wong, J., et al.
Published: (2016)
by: Wong, J., et al.
Published: (2016)
Doxorubicin action on mitochondria: relevance to osteosarcoma therapy?
by: Armstrong, J., et al.
Published: (2015)
by: Armstrong, J., et al.
Published: (2015)
RNA interference silencing of interleukin-6 in mesenchymal stromal cells and antitumour efficacy against multiple myeloma cells
by: Teoh, Hoon Koon
Published: (2015)
by: Teoh, Hoon Koon
Published: (2015)
Thiolated pectin–doxorubicin conjugates: Synthesis, characterization and anticancer activity studies
by: Cheewatanakornkool, K., et al.
Published: (2017)
by: Cheewatanakornkool, K., et al.
Published: (2017)
Antitumour-promoting and antitumour activities of the crude extract from the leaves of Juniperus chinensis
by: Ali, Abdul Manaf, et al.
Published: (1996)
by: Ali, Abdul Manaf, et al.
Published: (1996)
Senolytic and mitogenic activities of Moringa oleifera Lam. leaf extract on culture expanded and doxorubicin oxidative stress-induced umbilical cord mesenchymal stem cells
by: Adamu, Muhammad Umar
Published: (2022)
by: Adamu, Muhammad Umar
Published: (2022)
Anti-Tumour Effect of a Chitosan Delivery System for Doxorubicin
by: Tan, M., et al.
Published: (2010)
by: Tan, M., et al.
Published: (2010)
Cardiomyocyte apoptosis vs autophagy with prolonged doxorubicin treatment: Comparison with osteosarcoma cells
by: Tacar, O., et al.
Published: (2015)
by: Tacar, O., et al.
Published: (2015)
Mesenchymal stem cells: from stem cells to sarcomas
by: Lye, Kwan Liang, et al.
Published: (2016)
by: Lye, Kwan Liang, et al.
Published: (2016)
Pigment epithelium-derived factor: a key mediator in bone homeostasis and potential for bone regenerative therapy
by: Baxter-Holland, M., et al.
Published: (2018)
by: Baxter-Holland, M., et al.
Published: (2018)
Stability of freeze-dried pH-responsive dextrin nanogels containing doxorubicin
by: Manchun, S., et al.
Published: (2016)
by: Manchun, S., et al.
Published: (2016)
Alginate bead-encapsulated PEDF induces ectopic bone formation in vivo in the absence of co-administered mesenchymal stem cells.
by: Elahy, M., et al.
Published: (2015)
by: Elahy, M., et al.
Published: (2015)
Mesenchymal stem cell therapy for sports injuries - from research to clinical practice
by: Looi, Qi Hao, et al.
Published: (2020)
by: Looi, Qi Hao, et al.
Published: (2020)
Engineered mesenchymal stem cells as treatment for cancers: opportunities, clinical applications and challenges
by: Shamsul Kamal, Aishah Amirah, et al.
Published: (2024)
by: Shamsul Kamal, Aishah Amirah, et al.
Published: (2024)
Mesenchymal stem cell-mediated T cell immunosuppression
by: Al-Graittee, Satar Jabbar Rahi, et al.
Published: (2017)
by: Al-Graittee, Satar Jabbar Rahi, et al.
Published: (2017)
Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model
by: Tan, M., et al.
Published: (2013)
by: Tan, M., et al.
Published: (2013)
Thyroid stem cells: concept and clinical implications
by: Nani ML,, et al.
Published: (2016)
by: Nani ML,, et al.
Published: (2016)
Mitogenic activity of mesenchymal stem cells on hematopoietic stem cells via cellular analysis and gene expression
by: Mohadeseh, Hashem Boroojerdi
Published: (2015)
by: Mohadeseh, Hashem Boroojerdi
Published: (2015)
Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosis
by: Friedhuber, A., et al.
Published: (2015)
by: Friedhuber, A., et al.
Published: (2015)
Characterisation and immunosuppressive activity of human cartilage-derived mesenchymal stem cells
by: Ramasamy, Rajesh, et al.
Published: (2018)
by: Ramasamy, Rajesh, et al.
Published: (2018)
Mesenchymal stem cell-mediated immunomodulation of microglia
by: Jose, Shinsmon
Published: (2013)
by: Jose, Shinsmon
Published: (2013)
Immunomodulatory potential of mesenchymal stem cells on microglia
by: Vidyadaran, Sharmili, et al.
Published: (2012)
by: Vidyadaran, Sharmili, et al.
Published: (2012)
Modulatory and regenerative potential of transplanted bone marrow derived mesenchymal stem cells on rifampicin-induced kidney toxicity
by: Danjuma, Lawal, et al.
Published: (2018)
by: Danjuma, Lawal, et al.
Published: (2018)
Ascochlorin enhances the sensitivity of doxorubicin leading to the reversal of epithelial-to-mesenchymal transition in hepatocellular carcinoma
by: Dai, X., et al.
Published: (2016)
by: Dai, X., et al.
Published: (2016)
Enhanced anti-tumor effect of pH-responsive dextrin nanogels delivering doxorubicin on colorectal cancer
by: Manchun, S., et al.
Published: (2015)
by: Manchun, S., et al.
Published: (2015)
Labeling of mesenchymal stem cells for MRI with single-cell sensitivity
by: Ariza de Schellenberger, Angela, et al.
Published: (2016)
by: Ariza de Schellenberger, Angela, et al.
Published: (2016)
Rescue of photoreceptor with human mesenchyme stem cell and human mesenchyme stem cell expressing erythropoietin in total degeneration of retina animal model
by: Catherine Bastion, Mae-Lynn, et al.
Published: (2022)
by: Catherine Bastion, Mae-Lynn, et al.
Published: (2022)
Investigating the Mechanism of Action of Antitumour Benzoprims
by: Hatfield, Amelia
Published: (2024)
by: Hatfield, Amelia
Published: (2024)
Molecular characterization of doxorubicin resistance and cancer stem cells in a canine mammary adenocarcinoma cell line
by: Sahabi, Kabiru
Published: (2018)
by: Sahabi, Kabiru
Published: (2018)
Visualization and Modeling of the In Vivo Distribution of Mesenchymal Stem Cells
by: Wang, H., et al.
Published: (2017)
by: Wang, H., et al.
Published: (2017)
Mesenchymal stem cell therapy for injured growth plate
by: Awang, Mohd Shukrimi, et al.
Published: (2013)
by: Awang, Mohd Shukrimi, et al.
Published: (2013)
Inhibitory effect of mesenchymal stem cells on lymphocyte proliferation.
by: Gao, K., et al.
Published: (2008)
by: Gao, K., et al.
Published: (2008)
Empowering mesenchymal stem cells for ocular degenerative disorders
by: Ding, Shirley Suet Lee, et al.
Published: (2019)
by: Ding, Shirley Suet Lee, et al.
Published: (2019)
Mesenchymal stem cell and microglia crosstalk in an inflammatory paradigm
by: Rahmat, Muhammad Zul'atfi
Published: (2013)
by: Rahmat, Muhammad Zul'atfi
Published: (2013)
Implications of the WNT Signalling Pathway for Adipose-derived Mesenchymal Stem Cells in a Breast Tumour
Environment
by: Visweswaran, Malini
Published: (2017)
by: Visweswaran, Malini
Published: (2017)
Deciphering the anti-tumour activity of human mesenchymal stem cells on haematopoietic tumour cell lines
by: Ramasamy, Rajesh
Published: (2016)
by: Ramasamy, Rajesh
Published: (2016)
Redox-responsive microbeads containing thiolated pectin-doxorubicin conjugate inhibit tumor growth and metastasis: An in vitro and in vivo study
by: Cheewatanakornkool, K., et al.
Published: (2018)
by: Cheewatanakornkool, K., et al.
Published: (2018)
Similar Items
-
Doxorubicin-induced death in tumour cells and cardiomyocytes: is autophagy the key to improving future clinical outcomes?
by: Tacar, O., et al.
Published: (2013) -
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
by: Tacar, O., et al.
Published: (2013) -
Novel pH-responsive dextrin nanogels for doxorubicin delivery to cancer cells with reduced cytotoxicity to cardiomyocytes and stem cells
by: Manchun, S., et al.
Published: (2014) -
Doxorubicin: The dogma and the bone
by: Wong, J., et al.
Published: (2016) -
Doxorubicin action on mitochondria: relevance to osteosarcoma therapy?
by: Armstrong, J., et al.
Published: (2015)